一个更新的评论解读了apigenin纳米结构作为在人类癌症中有前途的治疗效率
Fahad Khan1, Mir Waqas Alam2, Seema Ramniwas3
1Center for Global Health Research Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
Current medicinal chemistry
|December 17, 2024
概括
作为一种天然化合物,apigenin (APG) 是一种有前途的抗癌剂,因为它对癌细胞有选择性的作用. 纳米技术增强了其传递,提高了治疗人类癌症的疗效.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
背景情况:
- 原蛋白 (APG) 通过调节细胞过程,如增殖,亡和转移,表现出抗癌性质.
- APG显示出对癌细胞的选择性超过健康细胞,这是相对于传统治疗的关键优势.
- APG的局限性包括水溶性差,口服吸收低,新陈代谢快,以及与血蛋白结合,导致治疗度低.
研究的目的:
- 在癌症治疗中审查apigenin (APG) 的生物方面.
- 讨论与APG的物理化学和药理动力学特性相关的挑战.
- 探索纳米技术在开发有效APG纳米配方治疗人类癌症中的作用.
主要方法:
- 对apigenin的生物活动和纳米配方的现有文献的审查.
- 分析基于纳米技术的战略,以克服APG的局限性.
- 在体内研究的总结证明APG纳米配方的有效性.
主要成果:
- 基于纳米技术的输送系统有效地提高了apigenin的水溶性和口服吸收.
- 原蛋白纳米配方改善药物向性,减少副作用.
- 在体内研究证实了apigenin纳米配方降低瘤大小的能力.
结论:
- 原蛋白 (APG) 作为抗癌治疗剂具有显著的潜力.
- 纳米技术提供了一种可行的策略,以提高阿比基宁在治疗人类癌症中的疗效.
- 进一步的临床试验是有必要的,以验证apigenin纳米配方在人类受试者的治疗潜力.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


